GLP-1 medicines now go beyond weight loss: semaglutide cut major cardiovascular events by ~20% in people with overweight/obesity and established CVD—even without diabetes. Learn who benefits, side effects, costs in Australia, and how lifestyle still matters. Same-day telehealth cardiometabolic consults available at Zelica.

Health risk scores convert your age, blood pressure, cholesterol and lifestyle into an absolute risk of events like heart attack or stroke. We select the right model, calibrate to Australian data, and compare your result with population percentiles and risk-age—then turn it into action: lifestyle coaching, BP and lipid therapy, and targeted screening. Partner with our Melbourne telehealth clinic for long-term, personalised prevention.